Contraceptive vaccines.
The basic principle of a contraceptive (or anti-fertility) vaccine is to use the body's own immune defence mechanisms to provide protection against an unplanned pregnancy. Factors such as: economic production, convenience of use, relatively long-lasting but reversible action, low failure rate, and the avoidance of mechanical devices or exogenous hormones make this approach a potentially attractive option for family planning programmes in both developing and developed countries. The major efforts in research and development have involved the prospect of active immunization against specific antigens of sperm, ovum, zygote and early embryo, and the pregnancy hormone hCG. Several anti-hCG vaccines have entered clinical trials and show promising results. These vaccines operate by preventing or interrupting pregnancy at the peri-implantation stage probably by neutralizing the luteotrophic action of hCG. The most refined vaccine is one directed against the unique C-terminal peptide on the beta-subunit of hCG. This vaccine provokes antibodies that are specific for hCG and do not cross react with hLH. Future research efforts aim to optimize the anti hCG approach, utilize new vaccine delivery systems, and broaden the spectrum of target antigens of potential utility for contraceptive vaccines.
Jones
W R
WR
Department of Obstetrics and Gynaecology, Finders Medical Centre, Bedford Park, Australia.
D000941:Antigens; D006063:Chorionic Gonadotropin / Q000276:immunology; D003269:Contraception, Immunologic; D004622:Embryo, Mammalian / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D010063:Ovum / Q000276:immunology*; D010920:Placenta / Q000276:immunology*; D011247:Pregnancy; D012106:Research; D013094:Spermatozoa / Q000276:immunology*; D013672:Technology
D000941:Antigens; D006063:Chorionic Gonadotropin